Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk
- 15 April 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (8) , 3008-3013
- https://doi.org/10.1182/blood-2002-08-2527
Abstract
Individuals with elevated prothrombin levels are at increased risk of venous thrombosis. To understand the mechanism behind this observation, we studied the effect of prothrombin concentration on thrombin generation and fibrin clot structure. The pattern of thrombin generation was directly related to the prothrombin level at all concentrations tested. From 0% to 300% of normal plasma levels of prothrombin, increasing the prothrombin concentration increased the initial rate, peak, and total amount of thrombin generated. Importantly, fibrin clot structure was also affected by the prothrombin concentration. Fibrin clots made from prothrombin concentrations less than 10% of plasma levels were weak and poorly formed. Fibrin clots made at 10% to 100% of plasma levels of prothrombin had similar fiber structures (mass-to-length ratio; μ). However, the fiber mass-to-length ratio decreased with increasing prothrombin levels more than 100% of plasma levels, in a dose-dependent manner. These results suggest that increased levels of prothrombin alter thrombin generation and clot structure. Specifically, elevated prothrombin levels produce clots with reduced fibrin mass-to-length ratios compared with normal clots. We hypothesize that this alteration in fibrin clot structure is an important determinant of the risk of thrombosis.Keywords
This publication has 57 references indexed in Scilit:
- Paradoxical inhibition of fibrinogen binding and potentiation of α-granule release by specific types of inhibitors of glycoprotein IIb–IIIaCardiovascular Research, 2000
- Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary interventionAmerican Heart Journal, 1999
- Dysfibrinogenemia and ThrombosisSeminars in Thrombosis and Hemostasis, 1999
- Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin GeneArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Journal of Clinical Investigation, 1996
- Effect of fibrin structure on plasmin-mediated dissolution of plasma clotsBlood Coagulation & Fibrinolysis, 1995
- Platelet procoagulant complex assembly in a tissue factor‐initiated systemBritish Journal of Haematology, 1994
- Characterization and Novel Purification of Recombinant Human Protein C from Three Mammalian Cell LinesNature Biotechnology, 1990
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- Functional evaluation of an inherited abnormal fibrinogen: fibrinogen “Baltimore”Journal of Clinical Investigation, 1971